The Challenge of Diabetes Mellitus in the Contemporary Percutaneous Coronary Intervention Era
Author:
- 1 December 2018
- journal article
- editorial
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 11 (24) , 2477-2479
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non–Insulin-Treated Diabetes MellitusJAMA Cardiology, 2016
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting StentsJACC, 2016
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary InterventionJAMA, 2016
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participantsThe Lancet, 2016
- Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in DiabetesNew England Journal of Medicine, 2015
- Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes MellitusJACC, 2014
- Achievement of Goals in U.S. Diabetes Care, 1999–2010New England Journal of Medicine, 2013
- Economic Costs of Diabetes in the U.S. in 2012Diabetes Care, 2013
- Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes MellitusCirculation, 2011
- Insulin Acutely Increases Fibrinogen Production in Individuals With Type 2 Diabetes but Not in Individuals Without DiabetesDiabetes, 2003